Eclampsia: Morbidity, mortality, and management

Clinical Obstetrics and Gynecology

Volumn 48, Issue 1, 2005, Pages 12-23

  Aagaard Tillery, Kjersti M ^a   Belfort, Michael A ^a,b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b St Mark's Hospital Salt Lake City   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIAZEPAM; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; NIFEDIPINE; NIMODIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN;

CONFERENCE PAPER; ECLAMPSIA; FETOTOXICITY; HEADACHE; HUMAN; METHEMOGLOBINEMIA; MORBIDITY; MORTALITY; PROGNOSIS; TACHYCARDIA;

ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; ECLAMPSIA; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 14844360661     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000153882.58132.ba     Document Type: Conference Paper

References (65)

1. American College of Obstetricians and Gynecologists. Diagnosis and Management of Preeclampsia and Eclampsia. ACOG Practice Bulletin No. 33. Washington, D.C.: ACOG; 2002.
2. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.
3. Coppage KH, Sibai BM. Hypertensive Emergencies in Obstetric Intensive Care Manual. 2nd ed. New York, NY: McGraw-Hill; 2004.
4. Walker JJ. Severe preeclampsia and eclampsia. Balliere's Best Pract Res Clin Obstet Gynaecol. 2000;14:57-71.
5. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99: 547-553.
6. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. Br Med J. 1994;309: 1395-1400.
7. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol. 1988;158:80-83.
8. Wilson ML, Goodwin TM, Pan VL, et al. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv. 2003;58:39-66.
9. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002;287:3183-3186.
10. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fins-like tyirosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111:649-658.
11. O'Dowd MJ, Philipp EE. The History of Obstetrics and Gynecology. New York, NY: Parthenon; 1994.
12. Zuspan FP. Problems encountered in the treatment of pregnancy-induced hypertension. Am J Obstet Gynecol. 1978;131:591-597.
13. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA. 1991;266:237-241.
14. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med. 1998;338: 701-705.
15. Sibai BM, Gordon T, Thom E, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obstet Gynecol. 1995;172:642-648.
16. Lie RT, Rasmussen S, Brunborg H, et al. Fetal and maternal contributions to risk of preeclampsia: a population based study. Br Med J. 1998;316:1343-1347.
17. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97:533-538.
18. Rochat RW, Koonin LM, Atrash HF, et al. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol. 1988;72:91-97.
19. Chames MD, Livingston JC, Ivester TS, et al. Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol. 2002;186: 1174-1177.
20. Agobe JT, Adewaze HO. Biochemical studies and delayed postpartum convulsions in Nigeria. In: Bomar J, MacGillivray I, Symonds EM, eds. Pregnancy Hypertension. Baltimore, MD: University Park Press; 1980.
21. Sibai BM. Eclampsia. VI. Maternal and perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol. 1990;163:1049-1054.
22. Conde-Agudelo A, Kafury-Goeta AC. Case-control study of risk factors for complicated eclampsia. Obstet Gynecol. 1997;90: 172-175.
23. Newman RB, Eddy GL. Association of eclampsia and hydatidiform mole: case report and review of the literature. Obstet Gynecol Surv. 1988;43:185-190.
24. Sibai BM, Anderson GD, Abdella TN, et al. Eclampsia III. Neonatal outcome, growth, and development. Am J Obstet Gynecol. 1983;146:307-315.
25. Coetzee EJ, Dommisse J, Anthony J. A randomized controlled trial of intravenous magnesium soleplate versus placebo in the management of women with severe preeclampsia. Br J Obstet Gynaecol. 1998;105: 300-303.
26. Magpie Trial Collaborative Group. Do women with preeclampsia, and their babies, benefit from magnesium sulfate? The Magpie Trial: a randomized placebo-controlled trial. Lancet. 2002;359:1877-1890.
27. Prichard JA, Cunningham FG, Prichard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol. 1984; 148:951-963.
28. Rugarn O, Carling Moen S, Berg G. Eclampsia at a tertiary hospital 1973 to 1999. Acta Obstet Gynecol Scand. 2004;83: 240-245.
29. Leitch CR. Cameron Ad, Walker JJ. The changing pattern of eclampsia over a 60-year period. Br J Obstet Gynaecol. 1997;104: 917-922.
30. El-Nafaty AU, Melah GS, Massa AA, et al. The analysis of eclamptic morbidity and mortality in the Specialist Hospital Gombe, Nigeria. J Obstet Gynaecol. 2004;24:142-147.
31. MacKay AP, Berg CJ, Atrash HK. Pregnancy related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97:533-538.
32. Lopez-Llera M. Main clinical types and sub-types of eclampsia. Am J Obstet Gynecol. 1992;166:4-9.
33. Sibai BM, McCubbin JH, Anderson GD, et al. Eclampsia. I. Observations from 67 recent cases. Obstet Gynecol. 1981;58:609-613.
34. Moller B, Lindmark G. Eclampsia in Sweden, 1976-1980. Acta Obstet Gynecol Scand. 1986;65:307-314.
35. Lawson J. Eclampsia. Clin Obstet Gynaecol. 1982;9:711-721.
36. Sibai BM, Abdella TN, Spinnato JA, et al. Eclampsia. V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol. 1986; 154:581-586.
37. Brown CE, Purdy P, Cunningham FG. Head computed tomographic scans in women with eclampsia. Am J Obstet Gynecol. 1988;159: 915-920.
38. Royburt M, Seidman DS, Serr DM, et al. Neurologic involvement in hypertensive disease of pregnancy. Obstet Gynecol Surv. 1991;46:656-664.
39. Digre KB, Varner MW, Osborn AG, et al. Cranial magnetic resonance imaging in severe preeclampsia vs eclampsia. Arch Neurol. 1993;50:399-406.
40. Sheehan HL, Lynch JB. Pathology of Toxaemia of Pregnancy. London: Churchill Livingston; 1973:524-582.
41. Usta IM, Sibai BM. Emergent management of puerperal eclampsia. Obstet Gynecol Clin North Am. 1995;22:315-333.
42. Roberts JM. Pregnancy related hypertension. In: Creasy RK, Resnik R, Iams JD, eds. Maternal Fetal Medicine: Principles and Practice. Philadelphia, PA: Saunders; 2004:859-899.
43. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. Br Med J. 1994;309: 1395-1400.
44. Roberts JM, Villar J, Arulkumaran S. Preventing and treating eclamptic seizures. Br Med J. 2002;325:609-610.
45. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002;100:369-377.
46. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103:981-991.
47. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol. 2004;190: 1520-1526.
48. Koos BJ, Purcell KJ. Judicious use of magnesium sulfate for eclampsia. OBG Manage. 2003:38-56.
49. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181-192.
50. Sibai BM, Caritis S, Hauth J, et al. What we have learned about preeclampsia. Semin Perinatol. 2003;27:239-246.
51. Belfort MA, Tooke-Miller C, Allen JC Jr, et al. Changes in flow velocity, resistance indices, and cerebral perfusion pressure in the maternal middle cerebral artery distribution during normal pregnancy. Acta Obstet Gynecol Scand. 2001;80:104-112.
52. Belfort MA, Varner MW, Dizon-Townson DS, et al. Cerebral perfusion pressure, and not cerebral blood flow, may be the critical determinant of intracranial injury in preeclampsia: a new hypothesis. Am J Obstet Gynecol. 2002;187:626-634.
53. Belfort MA, Anthony J, Saade GR, et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med. 2003;348:304-311.
54. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:210-215.
55. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345:1455-1463.
56. 4 therapy in preeclampsia-eclampsia. Obstet Gynecol. 1981;57:199-202.
57. Paul RH, Koh KS, Bernstein SG. Changes in fetal heart rate and uterine contraction patterns associated with eclampsia. Am J Obstet Gynecol. 1978;130:165-169.
58. Nassar AH, Adra AM, Chakhtoura N, et al. Severe preeclampsia remote from term: labor induction or elective cesarean delivery? Am J Obstet Gynecol. 1998;179:1210-1213.
59. Sibai BM, Mercer BM, Schiff E, et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994;171:818-822.
60. Wallace DH, Leveno KJ, Cunningham FG, et al. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe preeclampsia. Obstet Gynecol. 1995;86:193-199.
61. Visser W, Wallenberg HC. Temporizing management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol. 1995;102:111-117.
62. Clark SL, Cotton DB. Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia. Am J Obstet Gynecol. 1988;158:453-458.
63. Mabie WC, Gonzalez AR, Sibai BM, et al. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 1987;70:328-333.
64. Scardo JA, Vermillion ST, Hogg BB, et al. Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies. Am J Obstet Gynecol. 1996;175:338-340.
65. Scardo JA, Vermillion ST, Newman RB, et al. A randomized, double blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies. Am J Obstet Gynecol. 1999;181:862-866.